8.95 (-%)
As of Dec 04, 2024
Source:
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Our approved products, VOQUEZNA , VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK , contain vonoprazan, an oral small molecule potassium-competitive acid blocker, or PCAB. PCABs are a novel class of medicines that block acid secretion in the stomach.
Country | United States |
Headquarters | florham park, new jersey |
Phone Number | (877) 742-8466 |
Industry | manufacturing |
CEO | Terrie Curran |
Website | www.phathompharma.com |